China Nuclear Construction announced that Shuangbai Fund, a subsidiary of the company, plans to transfer 18.57% of its shares, and transfer 13.15% of its new assets from China, with a transaction consideration of about 889 million yuan; CNNC Science and Innovation will transfer 5.42%, with a transaction consideration of about 362 million yuan. As a shareholder of CNNC 23, the company plans to relinquish priority purchasing rights. At the same time, the shareholder of CCN5, a subsidiary of the company, Jiaobin Investment plans to transfer 18.21% of its shares to CNNC Science and Technology Innovation, with a transaction consideration of about 300 million yuan. As a shareholder of CNNC 5, the company also plans to relinquish priority purchasing rights. The above transaction constitutes a related transaction, but it does not constitute a major asset restructuring, and there is no need to submit it to the company's shareholders' meeting for review.

China Nuclear Construction announced that Shuangbai Fund, a subsidiary of the company, plans to transfer 18.57% of its shares, and transfer 13.15% of its new assets from China, with a transaction consideration of about 889 million yuan; CNNC Science and Innovation will transfer 5.42%, with a transaction consideration of about 362 million yuan. As a shareholder of CNNC 23, the company plans to relinquish priority purchasing rights. At the same time, the shareholder of CCN5, a subsidiary of the company, Jiaobin Investment plans to transfer 18.21% of its shares to CNNC Science and Technology Innovation, with a transaction consideration of about 300 million yuan. As a shareholder of CNNC 5, the company also plans to relinquish priority purchasing rights. The above transaction constitutes a related transaction, but it does not constitute a major asset restructuring, and there is no need to submit it to the company's shareholders' meeting for review.